Bridgefront Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-36,123
Closed -$2.23M 707
2025
Q4
$2.23M Buy
+36,123
New +$2.21M 0.56% 28
2025
Q3
Sell
-2,712
Closed -$217K 766
2025
Q2
$217K Buy
+2,712
New +$227K 0.06% 531
2023
Q4
Sell
-4,297
Closed -$246K 522
2023
Q3
$246K Buy
+4,297
New +$260K 0.17% 265
2023
Q2
Sell
-4,736
Closed -$297K 613
2023
Q1
$297K Buy
4,736
+296
+7% +$18.5K 0.18% 214
2022
Q4
$278K Buy
+4,440
New +$255K 0.19% 222

Other funds holding PBH

Bridgefront Capital's PBH Position: Q1 2026 in Review

Bridgefront Capital sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 36,123 shares — an estimated $2.23M sold.

Bridgefront Capital first reported a position in PBH in Q4 2022 and held it in 5 quarters. The position peaked at $2.23M in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Bridgefront Capital reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 36,123 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2.23M.
  • Bridgefront Capital first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 5 quarters.
  • Bridgefront Capital's Prestige Consumer Healthcare position peaked at $2.23M in Q4 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.